Diagnosticos da America (BSP:DASA3) EPS (Basic): R$-0.83 (TTM As of Mar. 2026)


BSP:DASA3 Diagnosticos da America SA BSP:DASA3
46 GF Score
Price R$2.78
GF Value R$1.70
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Diagnosticos da America EPS (Basic)?

Diagnosticos da America BSP:DASA3 -1.42% 46 EPS (Basic) is R$-0.83 as of Mar. 2026. GuruFocus rates BSP:DASA3 with a GF Score™ of 46/100 and a GF Value™ of R$1.70 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Diagnosticos da America's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was R$-0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was R$-0.83.

Diagnosticos da America's EPS (Diluted) for the three months ended in Mar. 2026 was R$-0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was R$-0.83.

Diagnosticos da America's EPS without NRI for the three months ended in Mar. 2026 was R$0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -0.78.

During the past 3 years, the average EPS without NRI Growth Rate was -14.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was -19.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Diagnosticos da America's highest 3-Year average EPS without NRI Growth Rate was 93.30% per year. The lowest was -49.20% per year. And the median was -10.80% per year.

Diagnosticos da America  (BSP:DASA3) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Diagnosticos da America EPS (Basic) Related Terms

Diagnosticos da America EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Diagnosticos da America's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnosticos da America EPS (Basic) Chart

Diagnosticos da America Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.40 -0.69 -1.56 -0.96 -0.92

Diagnosticos da America Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.09 -0.14 0.08 -0.76 -0.00
BSP:DASA3
46GF Score
Diagnosticos da America SA BSP:DASA3
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diagnosticos da America EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Diagnosticos da America's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1151.989-0)/1255.007
=-0.92

Diagnosticos da America's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.919-0)/1255.007
=-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-0.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of R$-0.83 mean?
Diagnosticos da America (BSP:DASA3) has a EPS (Basic) of R$-0.83 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Diagnosticos da America and its competitors.
Is Diagnosticos da America's EPS (Basic) too high?
Diagnosticos da America's current EPS (Basic) is R$-0.83. Overall, Diagnosticos da America has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Diagnosticos da America's EPS (Basic) compare to TMO and DHR?
Diagnosticos da America's EPS (Basic) of R$-0.83 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Diagnostics & Research company?
A good EPS (Basic) depends on the Medical Diagnostics & Research industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Diagnosticos da America and its competitors. Diagnosticos da America's current EPS (Basic) is R$-0.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnosticos da America stock overvalued right now?
Based on GuruFocus' analysis, Diagnosticos da America (BSP:DASA3) is currently considered Significantly Overvalued. The stock's GF Value™ is R$1.70, compared to a current price of R$2.78 — trading 63.5% above its estimated fair value. The current EPS (Basic) is R$-0.83. Diagnosticos da America's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Diagnosticos da America (BSP:DASA3), the current EPS (Basic) is R$-0.83 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diagnosticos da America (BSP:DASA3) Overvalued in 2026?

Based on GuruFocus' analysis, Diagnosticos da America stock appears to be overvalued. The current stock price of R$2.78 is trading 63.5% above its estimated GF Value™ of R$1.70. GuruFocus considers Diagnosticos da America to be Significantly Overvalued.

Key valuation signals for BSP:DASA3:

  • EPS (Basic): R$-0.83
  • GF Value™: R$1.70 vs. price of R$2.78 (63.5% above fair value)
  • GF Score™: 46/100 with 3 warning signs

No single metric tells the full story. See the BSP:DASA3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diagnosticos da America Business Description

Address Avenida Jurua, 434, Alphaville, Barueri, SP, BRA, 06455-010
Diagnosticos da America SA operates as a medical diagnostics company in Brazil. The company offers clinical analysis, diagnostic imaging tests, and patient service centers. It has three operating segments. Outpatient care services and care coordination includes Diagnosis and health management, Hospitals and oncology include Medical and hospital services & Foreign operations include Diagnosis. The majority is from the Hospitals and oncology segment. Geographically, it operates in Brazil and South America (Argentina, Uruguay, Chile and Colombia).
46GF Score

Get the complete analysis for BSP:DASA3

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$2.78
Price
R$1.70
GF Value